Valeant Pharmaceuticals International (VRX) announced a public offering of its common shares to raise gross proceeds of approximately $1.75 billion after the close Monday. The stock is now down 0.82 on 16K shares.
Valeant Pharmaceuticals traded in a range for the majority of Monday's session and closed up by 0.62 at $84.82. The stock has been moving in a narrow range for the last 2 weeks.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.